Search
Patexia Alejandro Freixes’s

Alejandro Freixes > News

  Over the course of 96 weeks, a Phase 3 clinical study trial was conducted to test the safety and efficacy of BARACLUDE monotherapy and BARACLUDE plus... Read More »
  SINGAPORE (Reuters) - Australia is set to unlock more than A$13 billion in government funds for clean energy that could boost investments for large solar... Read More »
  CAPE CANAVERAL, Florida (Reuters) - NASA plans to add a $370 million unmanned test flight of a new deep-space capsule designed to send astronauts to... Read More »
Two major pharmaceutical companies, Amylin Pharmaceuticals Inc (“Amylin”) and Eli Lilly and Company (“Lilly”), announced today their plans to... Read More »
  CAMBRIDGE (Reuters) - Mark Zuckerberg returned to Harvard officially for the first time Monday, winning a warm welcome from the university where he created ... Read More »
  LONDON (Reuters) - An experimental antidepressant from AstraZeneca Plc and Targacept Inc failed to meet the goal of changing a key depression rating score... Read More »
  TORONTO (Reuters) - Canadian-based e-reading service Kobo Inc will be acquired by Japan's Rakuten Inc for $315 million, the companies said in a release ... Read More »
  (Reuters) - Facebook has picked up a team of mobile technology developers from a small San Francisco startup company, bolstering the social networking... Read More »
  MOSCOW (Reuters) - Russia hopes to end a humiliating two-decade absence from deep space with the launch on Wednesday of an ambitious three-year mission to... Read More »
  ZURICH (Reuters) - Novartis' Ilaris helps patients with the most serious form of childhood arthritis, a second late-stage study has shown, further... Read More »
    NEW YORK (Reuters) - It may take a breakthrough treatment for Alzheimer's disease to match the $130 billion lifetime sales record of... Read More »
  WASHINGTON (Reuters) - The United States should be more open about its development of offensive cyber weapons and spell out when it will use them as it... Read More »
  Abbott announced today, at the American College of Rheumatology Annual Scientific Meeting  in Chicago, the results of their Phase-3 ABILITY-1 trial... Read More »
SAN FRANCISCO (Reuters) - A German court granted a preliminary injunction against Apple Inc in a patent infringement case that banned the California company from... Read More »
  (Reuters) - Sprint Nextel must give AT&T hundreds of thousands of additional documents that the giant telecommunications company wants for a legal... Read More »
  NEW YORK (Reuters) - Barnes & Noble Inc introduced a new Nook to compete against Amazon.com Inc's Kindle Fire, entering the lower-end tablet war... Read More »
  LONDON (Reuters) - Computer analysis of brain scans could help predict how serious or long term a psychotic patient's illness may become and help... Read More »
(Reuters) - A genetically engineered smallpox vaccine reduced the risk of death for patients with advanced liver cancer by nearly 60 percent in a mid-stage study... Read More »
BRUSSELS (Reuters) - EU regulators are investigating whether Samsung Electronics Co Ltd and Apple Inc have breached EU antitrust laws with patent infringement claims... Read More »
  BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which... Read More »
Menu